case_images: PMC3415789_01
case_images: Comparative study of upper abdomen MRI shows liver parenchyma with an increased signal in the left image due to increases in iron. On the right, after six months of treatment with deferasirox, a reduction in iron was observed by the MRI signal attenuation
case_images: rbhh-33-389-g01.jpg
case_images: PMC3415789_01_rbhh-33-389-g01.jpg
case_images: F1
case_images: A liver MRI in that period showed a reduction in iron deposits (Figure 1).
case_images: PMC3415789_02
case_images: Comparative study of brain MRI before (left) and six months after starting treatment with deferasirox (right) shows no change in the signal of basal ganglia structures
case_images: rbhh-33-389-g02.jpg
case_images: PMC3415789_02_rbhh-33-389-g02.jpg
case_images: F2
case_images: A liver MRI in this period, as opposed to the brain MRI (Figure 2), showed reductions in iron deposits.